Epidemiology and Natural History of NAFLD and NASH

McCullough, 2005, The epidemiology and risk factors of NASH, 23 Mofrad, 2003, Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values, Hepatology, 37, 1286, 10.1053/jhep.2003.50229 Ong, 2005, Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients, Obes Surg, 15, 310, 10.1381/0960892053576820 Clark, 2003, The prevalence and etiology of elevated aminotransferase levels in the united states, Am J Gastroenterol, 98, 960, 10.1111/j.1572-0241.2003.07486.x Prati, 2002, Updated definitions of healthy ranges for serum alanine aminotransferase levels, Ann Intern Med, 137, 1, 10.7326/0003-4819-137-1-200207020-00006 Ruhl, 2003, Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the united states, Gastroenterology, 124, 71, 10.1053/gast.2003.50004 Clark, 2002, Nonalcoholic fatty liver disease, Gastroenterology, 122, 1649, 10.1053/gast.2002.33573 Saadeh, 2002, The utility of radiological imaging in nonalcoholic fatty liver disease, Gastroenterology, 123, 745, 10.1053/gast.2002.35354 Browning, 2004, Prevalence of hepatic steatosis in an urban population in the united states: impact of ethnicity, Hepatology, 40, 1387, 10.1002/hep.20466 Suzuki, 2005, Chronological development of elevated aminotransferases in a nonalcoholic population, Hepatology, 41, 64, 10.1002/hep.20543 Hamaguchi, 2005, The metabolic syndrome as a predictor of nonalcoholic fatty liver disease, Ann Intern Med, 143, 722, 10.7326/0003-4819-143-10-200511150-00009 Omagari, 2002, Fatty liver in non-alcoholic non-overweight japanese adults: incidence and clinical characteristics, J Gastroenterol Hepatol, 17, 1098, 10.1046/j.1440-1746.2002.02846.x Ground, 1982, Liver pathology in aircrew, Aviat Space Environ Med, 53, 14 Hilden, 1977, Liver histology in a ‘normal’ population—examinations of 503 consecutive fatal traffic casualties, Scand J Gastroenterol, 12, 593, 10.3109/00365527709181339 Nomura, 1988, Prevalence of fatty liver in a general population of Okinawa, Japan, Jpn J Med, 27, 142, 10.2169/internalmedicine1962.27.142 Shen, 2003, Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: an epidemiological survey, World J Gastroenterol, 9, 1106, 10.3748/wjg.v9.i5.1106 Lai, 2002, Epidemiology of fatty liver in a hospital-based study in Taiwan, South Med J, 95, 1288, 10.1097/00007611-200295110-00012 Nonomura, 1992, Clinicopathologic study of alcohol-like liver disease in non-alcoholics; non-alcoholic steatohepatitis and fibrosis, Gastroenterol Jpn, 27, 521, 10.1007/BF02777789 Bedogni, 2005, Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study, Hepatology, 42, 44, 10.1002/hep.20734 Farrell, 2006, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatology, 43, S99, 10.1002/hep.20973 Ioannou, 2006, The prevalence and predictors of elevated serum aminotransferase activity in the united states in 1999–2002, Am J Gastroenterol, 101, 76, 10.1111/j.1572-0241.2005.00341.x Kojima, 2003, Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background, J Gastroenterol, 38, 954, 10.1007/s00535-003-1178-8 Liangpunsakul, 2005, Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third national health and nutrition survey (NHANES III), Am J Med Sci, 329, 111, 10.1097/00000441-200503000-00001 Kemmer, 2001 Dixon, 2001, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese, Gastroenterology, 121, 91, 10.1053/gast.2001.25540 Daniel, 1999, Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients, Am J Gastroenterol, 94, 3010, 10.1111/j.1572-0241.1999.01451.x Skelly, 2001, Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology, J Hepatol, 35, 195, 10.1016/S0168-8278(01)00094-0 Crespo, 2001, Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis?, Obes Surg, 11, 254, 10.1381/096089201321336548 Fan, 2005, Prevalence of and risk factors for fatty liver in a general population of Shanghai, China, J Hepatol, 43, 508, 10.1016/j.jhep.2005.02.042 Kagansky, 2004, Non-alcoholic fatty liver disease—a common and benign finding in octogenarian patients, Liver Int, 24, 588, 10.1111/j.1478-3231.2004.0969.x Weston, 2005, Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease, Hepatology, 41, 372, 10.1002/hep.20554 Caldwell, 2002, Is NASH underdiagnosed among African Americans?, Am J Gastroenterol, 97, 1496, 10.1111/j.1572-0241.2002.05795.x Falck-Ytter, 2001, Clinical features and natural history of nonalcoholic steatosis syndromes, Semin Liver Dis, 21, 17, 10.1055/s-2001-12926 Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome, Hepatology, 37, 917, 10.1053/jhep.2003.50161 Pagano, 2002, Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association, Hepatology, 35, 367, 10.1053/jhep.2002.30690 Ludwig, 1980, Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease, Mayo Clin Proc, 55, 434 Lee, 1989, Nonalcoholic steatohepatitis: a study of 49 patients, Hum Pathol, 20, 594, 10.1016/0046-8177(89)90249-9 Powell, 1990, The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years, Hepatology, 11, 74, 10.1002/hep.1840110114 Cortez-Pinto, 1999, Non-alcoholic fatty liver: another feature of the metabolic syndrome?, Clin Nutr, 18, 353, 10.1016/S0261-5614(99)80015-6 Matteoni, 1999, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 116, 1413, 10.1016/S0016-5085(99)70506-8 Angulo, 1999, Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis, Hepatology, 30, 1356, 10.1002/hep.510300604 Chitturi, 2002, NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome, Hepatology, 35, 373, 10.1053/jhep.2002.30692 Diehl, 1988, Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury, Gastroenterology, 95, 1056, 10.1016/0016-5085(88)90183-7 Marchesini, 1999, Association of nonalcoholic fatty liver disease with insulin resistance, Am J Med, 107, 450, 10.1016/S0002-9343(99)00271-5 Ong, 2005, Approach to the diagnosis and treatment of nonalcoholic fatty liver disease, Clin Liver Dis, 9, 617, 10.1016/j.cld.2005.07.002 Adams, 2005, The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies, J Hepatol, 42, 132, 10.1016/j.jhep.2004.09.012 Harrison, 2003, The natural history of nonalcoholic fatty liver disease: a clinical histopathological study, Am J Gastroenterol, 98, 2042, 10.1111/j.1572-0241.2003.07659.x Day, 2002, Pathogenesis of steatohepatitis, Best Pract Res Clin Gastroenterol, 16, 663, 10.1053/bega.2002.0333 Caldwell, 2005, The clinical outcome of NAFLD including cryptogenic cirrhosis, 168 Adams, 2005, The natural history of nonalcoholic fatty liver disease: a population-based cohort study, Gastroenterology, 129, 113, 10.1053/j.gastro.2005.04.014 Teli, 1995, The natural history of nonalcoholic fatty liver: a follow-up study, Hepatology, 22, 1714, 10.1002/hep.1840220616 Dam-Larsen, 2004, Long term prognosis of fatty liver: risk of chronic liver disease and death, Gut, 53, 750, 10.1136/gut.2003.019984 Ong, 2003, Nonalcoholic fatty liver disease (NAFLD)—two decades later: are we smarter about its natural history?, Am J Gastroenterol, 98, 1915, 10.1111/j.1572-0241.2003.07667.x Lindor, 2004, Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial, Hepatology, 39, 770, 10.1002/hep.20092 Fassio, 2004, Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies, Hepatology, 40, 820 Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423 El-Serag, 2004, Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma, Gastroenterology, 126, 460, 10.1053/j.gastro.2003.10.065 Ioannou, 2003, Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study, Gastroenterology, 125, 1053, 10.1016/S0016-5085(03)01200-9 Villanova, 2005, Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease, Hepatology, 42, 473, 10.1002/hep.20781 Targher, 2005, Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease, Hepatology, 42, 974, 10.1002/hep.20894 Brea, 2005, Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study, Arterioscler Thromb Vasc Biol, 25, 1045, 10.1161/01.ATV.0000160613.57985.18 McPherson, 2005, Circulatory dysfunction in NAFLD—which is first, which is last, and what do we do in between?, Hepatology, 42, 270, 10.1002/hep.20834 Ratziu, 2002, Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis, Hepatology, 35, 1485, 10.1053/jhep.2002.33324 Hui, 2003, Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C, Hepatology, 38, 420, 10.1053/jhep.2003.50320 Cotrim, 2000, Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?, Am J Gastroenterol, 95, 3018, 10.1111/j.1572-0241.2000.03241.x Zen, 2001, Hepatocellular carcinoma arising in non-alcoholic steatohepatitis, Pathol Int, 51, 127, 10.1046/j.1440-1827.2001.01174.x Shimada, 2002, Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis, J Hepatol, 37, 154, 10.1016/S0168-8278(02)00099-5 Caldwell, 1999, Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease, Hepatology, 29, 664, 10.1002/hep.510290347 Poonawala, 2000, Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study, Hepatology, 32, 689, 10.1053/jhep.2000.17894 Ong, 2001, Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease, Liver Transpl, 7, 797, 10.1053/jlts.2001.24644 Bugianesi, 2002, Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma, Gastroenterology, 123, 134, 10.1053/gast.2002.34168 Marrero, 2002, NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the united states, Hepatology, 36, 1349, 10.1053/jhep.2002.36939 Ong, 2002, Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?, Gastroenterology, 123, 375, 10.1053/gast.2002.34453 Kim, 1996, Recurrence of nonalcoholic steatohepatitis following liver transplantation, Transplantation, 62, 1802, 10.1097/00007890-199612270-00021 Carson, 1997, Recurrence of nonalcoholic steatohepatitis in a liver transplant recipient, Liver Transpl Surg, 3, 174, 10.1002/lt.500030211 Molloy, 1997, Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation, Liver Transpl Surg, 3, 177, 10.1002/lt.500030212 Contos, 2001, Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis, Liver Transpl, 7, 363, 10.1053/jlts.2001.23011 Charlton, 2001, Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease, Liver Transpl, 7, 608, 10.1053/jlts.2001.25453 Sutedja, 2004, Revealing the cause of cryptogenic cirrhosis by posttransplant liver biopsy, Transplant Proc, 36, 2334, 10.1016/j.transproceed.2004.07.003